BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38720427)

  • 1. Stereotactic radiosurgery and radiotherapy for brainstem metastases: An international multicenter analysis.
    Ehret F; Rueß D; Blanck O; Fichte S; Chatzikonstantinou G; Wolff R; Mose L; Mose S; Fortmann T; Lehrke R; Turna M; Caglar HB; Mortasawi F; Bleif M; Krug D; Ruge MI; Fürweger C; Muacevic A
    Int J Cancer; 2024 May; ():. PubMed ID: 38720427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractionated stereotactic radiotherapy as a primary or salvage treatment for large brainstem metastasis.
    Chatzikonstantinou G; Wolff R; Tselis N
    J Cancer Res Ther; 2022; 18(6):1604-1609. PubMed ID: 36412418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation Necrosis Following Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy with High Biologically Effective Doses for Large Brain Metastases.
    Johannwerner L; Werner EM; Blanck O; Janssen S; Cremers F; Yu NY; Rades D
    Biology (Basel); 2023 Apr; 12(5):. PubMed ID: 37237469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic radiosurgery for the treatment of brainstem metastases: a multicenter retrospective study.
    Nicosia L; Navarria P; Pinzi V; Giraffa M; Russo I; Tini P; Giaj-Levra N; Alongi F; Minniti G
    Radiat Oncol; 2022 Aug; 17(1):140. PubMed ID: 35945597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FSRT vs. SRS in Brain Metastases-Differences in Local Control and Radiation Necrosis-A Volumetric Study.
    Putz F; Weissmann T; Oft D; Schmidt MA; Roesch J; Siavooshhaghighi H; Filimonova I; Schmitter C; Mengling V; Bert C; Frey B; Lettmaier S; Distel LV; Semrau S; Fietkau R
    Front Oncol; 2020; 10():559193. PubMed ID: 33102223
    [No Abstract]   [Full Text] [Related]  

  • 7. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.
    Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J
    J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
    El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
    Front Oncol; 2020; 10():693. PubMed ID: 32477942
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
    Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose versus fractionated stereotactic radiotherapy for brain metastases.
    Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reirradiation of metastases of the central nervous system: part 1-brain metastasis.
    Rades D; Simone CB; Wong HCY; Chow E; Lee SF; Johnstone PAS
    Ann Palliat Med; 2024 Mar; ():. PubMed ID: 38509654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linac-Based Fractionated Stereotactic Radiotherapy with a Micro-Multileaf Collimator for Brainstem Metastasis.
    Sugimoto T; Matsuda R; Tamamoto T; Hontsu S; Yamaki K; Miura S; Park YS; Nakase H; Hasegawa M
    World Neurosurg; 2019 Dec; 132():e680-e686. PubMed ID: 31442651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linac-based stereotactic radiosurgery and fractionated stereotactic radiotherapy with a micro-multileaf collimator for brain metastasis in the primary motor cortex.
    Matsuda R; Hasegawa M; Tamamoto T; Ochi T; Miyasaka T; Inooka N; Hontsu S; Miura S; Takeshima Y; Tamura K; Yamada S; Nishimura F; Nakagawa I; Motoyama Y; Park YS; Nakase H
    J Radiat Res; 2022 Jan; 63(1):63-70. PubMed ID: 34927204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brainstem metastases treated with stereotactic radiosurgery: safety, efficacy, and dose response.
    Trifiletti DM; Lee CC; Winardi W; Patel NV; Yen CP; Larner JM; Sheehan JP
    J Neurooncol; 2015 Nov; 125(2):385-92. PubMed ID: 26341374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases.
    Hirata M; Yasui K; Oota N; Ogawa H; Onoe T; Maki S; Ito Y; Hayashi K; Asakura H; Murayama S; Mitsuya K; Deguchi S; Nakamura K; Hayashi N; Nishimura T; Harada H
    Radiat Oncol; 2022 Dec; 17(1):213. PubMed ID: 36578021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.
    Cho KH; Hall WA; Gerbi BJ; Higgins PD; McGuire WA; Clark HB
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1133-41. PubMed ID: 10613305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
    Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
    Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and the Role of Primary Histology Following LINAC-based Stereotactic Radiation for Sarcoma Brain Metastases.
    Sim AJ; Ahmed KA; Keller A; Figura NB; Oliver DE; Sarangkasiri S; Robinson TJ; Johnstone PAS; Yu HM; Naghavi AO
    Am J Clin Oncol; 2020 May; 43(5):356-361. PubMed ID: 32217854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.